Skip to main content
Quest Diagnostics

Anti-Nucleocapsid SARS-CoV-2 Antibody Seroprevalence in Previously Infected Persons With Immunocompromising Conditions-United States, 2020–2022

Anti-Nucleocapsid SARS-CoV-2 Antibody Seroprevalence in Previously Infected Persons With Immunocompromising Conditions-United States, 2020–2022

Authors: Bratcher A, Jones JM, Meyer WA 3rd, Waheed R, Yazgi H, Harris A, Gundlapalli AV, Clarke Ken

Citation: PLoS One. 2025 Jan 8;20(1):e0313620. doi: 10.1371/journal.pone.0313620.

Specialties: Infectious disease, Immunology, COVID-19

Related content

Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
Nucleocapsid and Spike Protein-Based Anti-SARS-CoV-2 Assay Performance in the Minority and Rural Coronavirus Insights Study: Characteristics of Socioeconomically Disadvantaged Populations with Health Disparities
Publication
Vitamin D Levels and SARS-CoV-2 Infection among Medically Underserved Populations in the Minority and Rural Coronavirus Insights Study

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.